USPTO serial 90650824
ENCOMPASS CONFIDIO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABRAMS, JACQUELINE WILLETTE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENCOMPASS CONFIDIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Towson, MD, US
Towson, MD, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
C. Brandon Browning
C. Brandon Browning Maynard, Cooper & Gale, PC1901 Sixth Avenue NorthSUITE 1700BIRMINGHAM, AL 35203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management consulting and advisory services for pharmacy operators, owners, brokers, pharmaceutical consultants, third party administrators, employers and employer health plan providers in the nature of pharmacy operations; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare claims data for business purposes on pharmaceutical use within a pharmacy benefits plan; Collection, reporting, and analysis of genetic testing data in regard to the use of pharmaceuticals and peer-to-peer clinician counseling on the pharmaceutical use of the tested products in the nature of pharmaceutical cost management services and drug utilization review services; Business advisory services, consultancy and information for pharmacy operators and owners with respect to pharmacy operations, profitability, product procurement, inventory management and regulatory and contract compliance | ACTIVE | — |
| 042 | Software as a Service (SaaS) services featuring software for generating reports, providing educational materials, and benefit recommendations, auditing and plan performance results, and providing data analytics, all in the field of pharmacies and pharmaceuticals; Technical consulting in the field of pharmaceutical studies, namely, collection, reporting, and analysis of genetic testing data in regard to the use of pharmaceuticals and peer-to-peer clinician counseling on the pharmaceutical use of the tested products | ACTIVE | — |
| 044 | Pharmaceutical advice, namely, collection, reporting, and analysis of genetic testing data in regard to the use of pharmaceuticals and peer-to-peer clinician counseling on the pharmaceutical use of the tested products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 17, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 17, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 15, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 18, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 18, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 29, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 10, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 10, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 10, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 10, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 15, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 24, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 20, 2021 | NWAP | NEW APPLICATION ENTERED | — |